Walgreens Boots Alliance (NASDAQ:WBA) Price Target Raised to $10.00 at Evercore ISI

Walgreens Boots Alliance (NASDAQ:WBA) had its price target raised by stock analysts at Evercore ISI from $7.50 to $10.00 in a report released on Wednesday, Benzinga reports. The firm currently has an “in-line” rating on the pharmacy operator’s stock. Evercore ISI’s price target would suggest a potential downside of 5.93% from the company’s current price.

Several other equities research analysts have also recently issued reports on the company. UBS Group cut their target price on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research note on Wednesday, July 3rd. Truist Financial reduced their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a report on Monday, October 7th. Bank of America lowered their target price on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research note on Wednesday, September 4th. TD Cowen dropped their price target on shares of Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Finally, Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $13.46.

Walgreens Boots Alliance Trading Up 2.0 %

Walgreens Boots Alliance stock traded up $0.21 during trading on Wednesday, reaching $10.63. 14,061,997 shares of the company were exchanged, compared to its average volume of 16,871,156. Walgreens Boots Alliance has a 52-week low of $8.22 and a 52-week high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. The stock’s 50 day simple moving average is $9.40 and its two-hundred day simple moving average is $13.23. The company has a market capitalization of $9.18 billion, a P/E ratio of -1.58, a PEG ratio of 1.06 and a beta of 0.70.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same period in the previous year, the firm earned $0.67 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 5.9% compared to the same quarter last year. On average, equities research analysts expect that Walgreens Boots Alliance will post 2.85 earnings per share for the current fiscal year.

Institutional Trading of Walgreens Boots Alliance

A number of institutional investors have recently added to or reduced their stakes in the stock. Iron Horse Wealth Management LLC lifted its position in shares of Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 1,300 shares during the period. Blue Trust Inc. boosted its position in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 1,081 shares in the last quarter. Continuum Advisory LLC grew its stake in Walgreens Boots Alliance by 71.2% in the 2nd quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,020 shares during the last quarter. Strategic Investment Solutions Inc. IL purchased a new position in Walgreens Boots Alliance during the 2nd quarter valued at about $34,000. Finally, New Covenant Trust Company N.A. acquired a new position in Walgreens Boots Alliance during the first quarter worth about $35,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.